Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/27/21 → 2/28/23 |
Funding
- Integrative Research Laboratories Sweden AB: $28,884.00
IRL790C005: A Randomized, Double-Blind, Placebo-Controlled, Phase IIb Study Evaluating the Efficacy of Mesdopetam on Daily ON-Time Without Troublesome Dyskinesia in Patients with Parkinson#s Disease
- Guduru, Zain (PI)